tiprankstipranks
Advertisement
Advertisement

AU:OCC Stock Latest News

Orthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
Company AnnouncementsOrthocell logs first Remplir sales in Canada, advancing global nerve repair rollout
4d ago
OCC
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
PremiumCompany Announcements
Orthocell’s Remplir Nerve Repair Device Posts Near-90% Success in Real-World Study
6d ago
OCC
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
PremiumCompany Announcements
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
14d ago
OCC
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
PremiumCompany Announcements
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
17d ago
OCC
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
19d ago
OCC
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
PremiumCompany AnnouncementsOrthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
19d ago
OCC
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
Premium
Company Announcements
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
20d ago
OCC
Orthocell courts investors with biotech presentation as global product rollout advances
Premium
Company Announcements
Orthocell courts investors with biotech presentation as global product rollout advances
1M ago
OCC
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
PremiumCompany Announcements
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
2M ago
OCC
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
PremiumCompany Announcements
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
2M ago
OCC
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
2M ago
OCC
Orthocell director Michael McNulty increases on‑market shareholding
PremiumCompany Announcements
Orthocell director Michael McNulty increases on‑market shareholding
2M ago
OCC
Orthocell Director Increases Shareholding Through On-Market Purchase
PremiumCompany AnnouncementsOrthocell Director Increases Shareholding Through On-Market Purchase
2M ago
OCC
Orthocell posts record half-year revenue as global expansion gains pace
Premium
Company Announcements
Orthocell posts record half-year revenue as global expansion gains pace
2M ago
OCC
Orthocell Issues Confidential US Market Update with Standard Legal Disclaimers
Premium
Company Announcements
Orthocell Issues Confidential US Market Update with Standard Legal Disclaimers
3M ago
OCC
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
PremiumCompany Announcements
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
3M ago
OCC
Orthocell Posts Record Revenue as Remplir Global Rollout Accelerates
PremiumCompany Announcements
Orthocell Posts Record Revenue as Remplir Global Rollout Accelerates
3M ago
OCC
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
PremiumCompany Announcements
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
4M ago
OCC
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
PremiumCompany Announcements
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
4M ago
OCC
Orthocell CEO Increases Shareholding Through Vesting of Performance Rights
PremiumCompany AnnouncementsOrthocell CEO Increases Shareholding Through Vesting of Performance Rights
4M ago
OCC
Orthocell Issues New Shares on Exercise of Performance Rights
Premium
Company Announcements
Orthocell Issues New Shares on Exercise of Performance Rights
4M ago
OCC
Orthocell Seeks ASX Quotation for 217,742 New Ordinary Shares
Premium
Company Announcements
Orthocell Seeks ASX Quotation for 217,742 New Ordinary Shares
4M ago
OCC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >